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Abstract
Objective: The purpose of the present study was to characterize the composition of 
the salivary microbiota and quantify salivary levels of inflammation-related proteins 
(neutrophil gelatinase-associated lipocalin [NGAL] and transferrin) in patients with 
psoriasis and compare data to those obtained in patients with periodontitis and orally 
healthy controls, respectively.
Materials and methods: Stimulated saliva samples from patients with psoriasis 
(n = 27), patients with periodontitis (n = 58), and orally healthy controls (n = 52) 
were characterized by means of next-generation sequencing of the 16S rRNA gene. 
Salivary levels of NGAL and transferrin were quantified using immunoassays.
Results: Linear discriminant effect size analysis showed that 52 (22 psoriasis-asso-
ciated and 30 periodontitis-associated) and 21 (8 psoriasis-associated and 13 orally 
healthy control-associated) bacterial taxa differentiated the salivary microbiota in 
patients with psoriasis from that of patients with periodontitis and orally healthy 
controls, respectively. Significantly lower mean salivary levels of NGAL (psoriasis: 
996 [std. error 320], periodontitis: 2,072 [295], orally healthy controls: 2,551 [345] 
ng/ml, p < .0001) and transferrin (psoriasis: 4.37 [0.92], periodontitis: 7.25 [0.88], 
orally healthy controls: 10.02 [0.94] ng/ml, p < .0001) were identified in patients with 
psoriasis.
Conclusions: Psoriasis associates with characteristics of the salivary microbiota and 
salivary levels of inflammation-related proteins, which are different from characteris-
tics in patients with periodontitis and orally healthy controls, respectively.
K E Y W O R D S
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1  | INTRODUC TION
Psoriasis is a chronic inflammatory disease, with a prevalence of 
approximately 2% in the western world (Nestle, Kaplan, & Barker, 
2009). The pathobiological mechanisms underlying psoriasis are 
not fully understood, but the driving factor is presumably aberrant 
activation of both the innate and the adaptive immune system, 
which causes characteristic local inflammatory reactions in the 
skin as well as systemic low-grade inflammation with increased 
circulating levels of inflammatory cytokines (Dowlatshahi, Voort, 
Arends, & Nijsten, 2013; Mahil, Capon, & Barker, 2015; Nestle et 
al., 2009). Periodontitis is a chronic inflammatory disease of the 
tooth supporting tissues, which affects as much as 50% of the 
adult population in the western world (Eke, Dye, Wei, Thornton-
Evans, & Genco, 2012). The hallmark of periodontitis is a chronic 
inflammatory reaction in the periodontal tissue that is driven, in 
part, by responses directed at the oral microbiota (Bartold & Van 
Dyke, 2017).
Several cross-sectional studies have shown a higher preva-
lence of periodontitis and increased periodontal disease activity 
in patients with psoriasis, as compared to orally healthy controls 
(Egeberg, Mallbris, Gislason, Hansen, & Mrowietz, 2017; Lazaridou 
et al., 2013; Preus, Khanifam, Kolltveit, Mørk, & Gjermo, 2010; 
Sharma, Raman, & Pradeep, 2015; Skudutyte-Rysstad, Slevolden, 
Hansen, Sandvik, & Preus, 2014; Üstün et al., 2013; Woeste, Graetz, 
Gerdes, & Mrowietz, 2019). Recently, these findings were con-
firmed in a systematic review and meta-analysis, which reported a 
significant psoriasis-associated risk of periodontitis (Ungprasert, 
Wijarnpreecha, & Wetter, 2017). Conversely, patients with psoria-
sis appear to have an increased risk of periodontitis (Keller & Lin, 
2012; Nakib, Han, Li, Joshipura, & Qureshi, 2013). Collectively, these 
studies indicate a bi-directional relationship between periodontitis 
and psoriasis, with one disease increasing risk of the other, and vice 
versa. Although shared inflammatory mechanisms may contribute to 
this relationship, the biological mechanisms behind these findings 
remain unclear.
Saliva is the fluid of the oral cavity, which besides being crit-
ical to maintenance of oral homeostasis harbors various biologi-
cal substances such as the salivary microbiota and inflammatory 
markers (Lynge Pedersen & Belstrom, 2019). The presence of un-
treated periodontitis has been shown to alter the composition of 
the salivary microbiota (Belstrom et al., 2017) and increase sali-
vary levels of inflammatory proteins such interleukin (IL)-1β and 
matrix metalloproteinase (MMP)-8 (Lee, Chen, Tu, Wu, & Chang, 
2018; Liukkonen, Gürsoy, Pussinen, Suominen, & Könönen, 2016; 
Sorsa et al., 2016). Thus, the composition of the salivary microbi-
ota and salivary levels of inflammatory markers have been sug-
gested as a proxy of oral and systemic health status (Yoshizawa 
et al., 2013). While psoriasis associates with periodontitis, it is not 
known whether psoriasis directly impacts these salivary markers 
of oral homeostasis.
The purpose of the present study was therefore to charac-
terize the composition of the salivary microbiota in patients with 
psoriasis. Furthermore, as inflammatory mechanisms includ-
ing neutrophils and presumably iron metabolism play important 
roles in psoriasis (Rocha-Pereira et al., 2004; Schon, Broekaert, 
& Erpenbeck, 2017) we aimed to quantify salivary levels of the 
inflammation-related proteins, neutrophil gelatinase-associated li-
pocalin (NGAL) and transferrin in patients with psoriasis. We com-
pared these data to those in patients with periodontitis and orally 
healthy controls, respectively, to test the hypothesis that psoriasis 
is linked with characteristics of the salivary microbiota and sali-
vary levels of inflammation-related proteins, which are different 
from characteristics in patients with periodontitis and oral healthy 
individuals, respectively.
2  | METHODS
2.1 | Study population
In the period from October 2018 to May 2019, a total of 142 in-
dividuals were screened for enrollment in the study. Patients 
with psoriasis were recruited at the Department of Dermatology, 
Herlev and Gentofte Hospital, whereas patients with periodonti-
tis and orally healthy controls were recruited at the Department of 
Odontology, University of Copenhagen. General inclusion criteria 
were age > 18 years and ≥20 remaining natural teeth. General ex-
clusion criteria included pregnancy, breast-feeding, and use of any 
systemic antibiotics 3 months prior to study participation. Patients 
with psoriasis were excluded if they had treatment-requiring peri-
odontitis, and patients with periodontitis were excluded if they had 
psoriasis. Accordingly, 13 patients with psoriasis were excluded as 
they had treatment-requiring periodontitis, and samples from 7 pa-
tients with psoriasis were excluded as they did not pass initial salivary 
sample quality control due to insufficient amount of bacterial DNA. 
Consequently, samples from 27 patients with psoriasis, 58 patients 
with periodontitis, and 52 orally healthy controls were included in the 
study. The study was performed in accordance with the Helsinki dec-
laration, and all participants signed an informed consent prior to par-
ticipation. The study was approved by the regional ethical committee 
(H-18013543) and reported to the local data authorization of the 
Faculty of Health and Medical Sciences, University of Copenhagen.
2.2 | Clinical examination and case definitions
Periodontal examination was performed in all patients with psoriasis 
by the same examiner (JME), and plaque, bleeding on probing (BOP), 
probing pocket depth (PPD), and clinical attachment level (CAL) were 
recorded at six sites per tooth (third molars excluded). Periodontitis 
was defined as BOP ≥ 25% of total sites, with minimum two teeth 
with clinical attachment level ≥ 4 mm and a minimum two teeth with 
PPD ≥ 6 mm (Kongstad et al., 2013), corresponding to stage 3 using 
the newly presented classification of periodontitis (Papapanou et al., 
2018).
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2.3 | Collection of saliva samples
Stimulated saliva samples were collected between 8.00 a.m. and 
15.00 p.m. Monday–Friday. The saliva samples were collected 
at least two hours after self-performed oral hygiene, and before 
any dental treatment to avoid bleeding and contamination. Two 
types of stimulated saliva samples were collected. First, a Salivette 
(Sarstedt) was used. The swab from the Salivette was placed in 
the mouth of each of the participants. The swab was removed 
after 2 min and stored in the suspended insert of the Salivette. 
Two Salivette saliva samples were collected from each participant. 
Next, a paraffin-stimulated saliva sample was collected as previ-
ously described (Bardow et al., 2014). The saliva was collected in 
plastic cups and split into two aliquots, which were transferred 
to Eppendorf tubes (Eppendorf Nordic). The Salivettes and the 
Eppendorf tubes were stored at –80° Celsius degrees until analysis.
2.4 | Sequencing and data analysis
Bacterial 16S rRNA gene-targeted amplicon sequencing was per-
formed using a custom dual-index protocol, as previously described 
(Kozich, Westcott, Baxter, Highlander, & Schloss, 2013). Custom 16S 
primers were used to amplify the V1-V3 regions of the 16S rRNA 
gene, which were designed to provide the best coverage of the 16S 
gene while maintaining high sensitivity. Libraries were prepared using 
a 22-cycle PCR, which reduces chimera formation (unless otherwise 
noted). Purification of final PCR products was done using Ampure 
XP beads, pooled in equal amounts, and gels were purified by the 
QIAGEN MinElute Gel Extraction Kit (Qiagen). Quantification of 
pooled purified libraries was performed using the NEBNext Library 
Quant Kit for Illumina (Illumina). The Illumina® MiSeq was used for 
sequencing of final libraries with a v2 reagent kit (500 cycles) at a 
10 p.m. loading concentration with >20% PhiX spike-in. The DADA2 R 
package (Callahan et al., 2016) was used to identify and quantify am-
plicon sequencing reads on the FastQC files obtained after demulti-
plexing with the Illumina MiSeq software, and low-quality sequences 
were removed using FastQC. Results of FastQC were compiled using 
MultiQC (Ewels, Magnusson, Lundin, & Käller, 2016). Trimmed and 
filtered reads were processed through the denoizing, concatenat-
ing read1 and read2 with a 10N spacer, and chimera removal steps 
of DADA2 to identify and quantify true amplicon sequence variants 
(ASV) present in the sample. Taxonomy of the identified ASVs was 
assigned using the RDP classifier algorithm (Wang, Garrity, Tiedje, & 
Cole, 2007) implemented in the DADA2 package with a training data-
set developed at The Forsyth Institute and based on the Extended 
Human Oral Microbe Database (eHOMD) (Chen et al., 2010).
2.5 | Analyses of NGAL and transferrin
The samples were thawed at RT, spun down at 2000G for 5 min, 
and transferred to standard 13-mm analysis tubes. NGAL was 
analyzed on the Siemens Vista 1500 platform (Siemens) using a 
NGAL Test assay (cat. nr. ST001RA), the NGAL Calibrator Kit (cat. 
nr. ST002CA), and the NGAL Control Kit (cat. nr ST003CA) all from 
Bioporto (Bioporto Diagnostics). Samples with NGAL concentration 
over 3,000 ng/ml were diluted 1:4, 1:9, or 1:19 in isotonic NaCl and 
reanalyzed. Transferrin concentration in saliva was measured on the 
Vista 1500 platform using the TRF Flex reagent in urine mode, as 
the transferrin concentration in saliva is low. The detection limit of 
NGAL and transferrin was 25 ng/ml and 2.46 mg/L, respectively. In 
case of measurements below detection limit, the value was set con-
servatively as the detection limit.
2.6 | Statistics
Since no previous data were available on salivary levels of NGAL 
and transferrin or the salivary microbiota in patients with psoriasis, 
the sample size was calculated using the clinical periodontal param-
eter, mean PPD. Based on findings from previous studies (Belstrøm 
et al., 2018; Üstün et al., 2013), the expected PPD in the periodon-
titis group was 3.4 ± 1.0 mm and the expected PPD in the psoria-
sis group was 2.8 mm. With fixed values of α = 0.05 and β = 0.10, 
the calculated sample size was n = 116, with 58 individuals in each 
group. Thus, the number of healthy controls was also set to n = 58. 
All parameters tested were checked for normality. Data which fol-
lowed a Gaussian distribution were compared using t test, chi-square 
test, and ANOVA, whereas non-parametric data were compared by 
Mann–Whitney U test, Friedman test, and Kruskal–Wallis H test with 
p < .05 considered as statistically significant. The core salivary mi-
crobiota was defined as bacterial genera and species present with a 
mean relative abundance >1% across all samples. The salivary micro-
biota were characterized and compared by means of predominant 
genera and species, relative abundance, α-diversity (Shannon index), 
principal component analysis, and linear discriminant effect size anal-
ysis (Segata et al., 2011). Data on relative abundance were corrected 
for multiple dependent associations using Benjamini–Hochberg cor-
rection (Hochberg & Benjamini, 1990). All statistics were computed 
with MeV (Saeed et al., 2006) and GraphPad Prism (GraphPad).
3  | RESULTS
3.1 | Background and clinical data
Background data of the study population are detailed in Table 1. A 
comparable age and gender distribution was observed between the 
three groups. A significantly higher number of current smokers were 
identified in the periodontitis group (p < .05), whereas a significantly 
higher proportion of patients with psoriasis reported to attend regu-
lar dental care, as compared to periodontitis patients and healthy 
controls (p < .05). A limited proportion of the study population re-
ported concurrent cardiovascular disease or diabetes. Patients 
with psoriasis were in good periodontal condition as expressed by 
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number of teeth (mean: 26, range: 21–28), PPD (mean: 3.0, range: 
2.4–3.4), and CAL (mean: 2.8, range: 2.0–3.9), despite having rela-
tively high percentages of BOP (mean: 63, range: 26–99) and plaque 
(mean: 82, range: 37–100).
3.2 | Sequence metadata
A total number of 137 samples passed quality control with a mean 
(range) of 33,591 (8,278–105,689) sequences per samples. In gen-
eral, 99.8 (96.2–100.0)% of the generated sequences could be iden-
tified at genus level, whereas 98.0% (93.7–99.8) of the sequences 
could be identified at species level. In total, 477 different taxa were 
identified. A comparable percentage of genus-level and species-level 
identifications were observed in all groups studied.
3.3 | Core salivary microbiota in psoriasis, 
periodontitis, and oral health
The composition of the predominant bacterial genera and species 
identified is presented in Figure 1a-b. The four most predominant 
bacterial genera identified in all three study groups, which constituted 
approximately 70% of the salivary microbiota, were Streptococcus, 
Prevotella, Veillonella, and Neisseria. At species level, the most pre-
dominant bacterial species was Prevotella melalogenica followed by 
Streptococcus salivarius. In general, the most predominant bacte-
rial species identified were Streptococcus, Prevotella, and Veillonella. 
No significant differences were observed in α-diversity and relative 
abundance of predominant genera or predominant species in the 
three groups. Furthermore, principal component analysis revealed a 
completely random distribution of saliva samples from patients with 
psoriasis, patients with periodontitis, and healthy controls (Figure 1c).
3.4 | Relative abundance and linear discriminant 
effect size analysis of salivary microbiota
A total of 18 bacterial species were identified with a significantly 
different relative abundance in saliva samples from patients 
with psoriasis, patients with periodontitis, and oral healthy con-
trols (Table 2, adjusted p < .001). A significantly higher relative 
abundance of specific proposed periodontal pathogens, such as 
Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, 
Prevotella intermedia, and Filifactor alocis, was identified in saliva 
samples from patients with periodontitis. Pairwise comparisons 
using linear discriminant effect size analysis showed that 52 (22 
psoriasis-associated and 30 periodontitis-associated; Figure 2a) 
taxa differentiated patients with psoriasis from patients with peri-
odontitis, 21 (8 psoriasis-associated and 13 orally healthy control-
associated; Figure 2b) taxa differentiated patients with psoriasis 
from orally healthy controls, and 78 (42 periodontitis-associated 
and 36 orally healthy control-associated; Figure 2c) taxa differ-
entiated patients with periodontitis from orally healthy controls, 
respectively.
3.5 | Salivary NGAL and transferrin levels
All samples were recorded with NGAL levels above detection limit, 
whereas transferrin levels were below detection limit in 30 samples.
A significantly lower mean salivary level of NGAL (996 [std. error 
320] ng/ml) was recorded in patients with psoriasis, as compared 
to patients with periodontitis (2,072 [295] ng/ml) and orally healthy 
controls (2,551 [345] ng/ml, p < .0001).
Salivary transferrin levels were also significantly lower in pa-
tients with psoriasis (4.37 [0.92] ng/ml), as compared to patients 
with periodontitis (7.25 [0.88] ng/ml) and orally healthy controls 
(10.02 [0.94] ng/ ml, p < .0001).
4  | DISCUSSION
The purpose of the present study was to characterize the composi-
tion of the salivary microbiota and measure salivary levels of NGAL 
and transferrin in patients with psoriasis, and compare these data to 
the characteristics in patients with periodontitis and orally healthy 
controls.
We found that psoriasis was associated with specific character-
istics of the salivary microbiota, which were different from patients 
 Psoriasis (n = 27)
Periodontitis 
(n = 58)
Orally healthy 
controls (n = 52)
Gender male/female 16/11 33/25 27/25
Age (mean, range) years 55.3 (38–74) 53.4 (38–76) 54.8 (40–80)
Smoking status (Non-/
former/current smoker)
15/10/2* 20/15/23 30/16/6*
Heart disease (Y/N) 0/27 5/53 8/44
Diabetes (Y/N) 2/25 4/54 4/48
Regular dental care (Y/N) 23/4* 17/41 28/24
*p < .05. 
TA B L E  1   Background data of the study 
groups
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with periodontitis and orally healthy controls (Figure 2a-b, Table 2). 
Furthermore, patients with psoriasis had significantly lower salivary 
NGAL and transferrin levels than patients with periodontitis and 
orally healthy controls. These data suggest that psoriasis impacts oral 
homeostasis and the significance of reduced levels salivary levels of 
NGAL and transferrin in psoriasis clearly also merits further study.
In the present study, 29% of the patients with psoriasis were 
excluded as they had treatment-requiring periodontitis. This find-
ing is in line with increased risk of periodontitis found in other 
studies (Skudutyte-Rysstad et al., 2014; Woeste et al., 2019). 
In a recently published paper, the prevalence of periodontitis in 
a Danish cohort ranged from 9.2% to 31.0% depending on the 
periodontal classification used (Kongstad, Enevold, Christensen, 
Fiehn, & Holmstrup, 2017). Thus, data from the present study sup-
port a psoriasis-associated risk of periodontitis. Notably, all pa-
tients with psoriasis, who were excluded based on the presence of 
treatment-requiring periodontitis, reported to attend regular den-
tal care, as compared to 54% of orally healthy controls, indicating 
that patients with psoriasis might be prone to periodontitis despite 
having regular dental care.
The core salivary microbiota identified in patients with psoria-
sis could not be differentiated from patients with periodontitis and 
orally healthy controls (Figure 1a-c). However, 18 bacterial species 
were identified with a significantly different relative abundance in 
the three groups studies (Table 2). Notably, the majority of these 
bacterial species, including the proposed periopathogen P. gingivalis, 
F I G U R E  1   Core salivary microbiota. (a) Relative abundance of predominant bacterial genera expressed as % of total sequences. (b) 
Relative abundance of predominant bacterial species expressed as % of total sequences. (c) Principal component analysis with x (PC1) and 
y-axis (PC2) as the two most decisive components collectively accounting for 33.7% of the variation. Sample denotation: psoriasis: blue, 
periodontitis: green, and oral health: red
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were identified with higher relative abundance in patients with 
periodontitis. Salivary levels of P. gingivalis have been reported to 
associate with periodontitis (Damgaard et al., 2019), and previous 
studies have shown a positive correlation of salivary and subgingival 
levels of P. gingivalis (Belstrøm et al., 2018; Nickles, Scharf, Röllke, 
Dannewitz, & Eickholz, 2017) suggesting that the salivary microbiota 
reflects local bacterial alterations associated with periodontitis.
Using linear discriminant effect size analysis, we identified 
unique characteristics of the salivary microbiota in psoriasis, 
as 52 (22 psoriasis-associated and 30 periodontitis-associated; 
Figure 2a) and 21 (8 psoriasis-associated and 13 health-associated; 
Figure 2b) taxa differed in psoriasis as compared to periodontitis 
and orally healthy controls, respectively. To the best of our knowl-
edge, this is the first study to characterize the salivary microbi-
ota in patients with psoriasis. On the other hand, several studies 
have demonstrated an impact of diabetes on the composition of 
the oral microbiota (Wang et al., 2019; Xiao et al., 2017), and two 
recent studies reported that periodontal bone loss in patients 
with rheumatoid arthritis was associated with alterations of the 
oral microbiota (Corrêa et al., 2019, 2016). In addition, dysbiosis of 
the salivary microbiota has been linked with inflammatory bowel 
disease (Xun, Zhang, Xu, Chen, & Chen, 2018). Thus, accumulated 
evidence suggests that systemic diseases, as exemplified in the 
current study by psoriasis, might impact the composition of the 
salivary microbiota.
We found significantly lower salivary levels of NGAL and trans-
ferrin in patients with psoriasis, as compared to patients with peri-
odontitis and orally healthy controls, respectively. To the best of 
our knowledge, salivary levels of these inflammation-related pro-
teins have not previously been reported in patients with psoriasis. 
TA B L E  2   Bacterial taxa with significantly different relative abundance
 
Psoriasis Periodontitis Orally healthy controls
p-valueRA Presence RA Presence RA Presence
Rothia mucilaginosa 
HMT681
0.330686 96.15385 1.064432422 100 0.051519542 88.46154 1.00E-11
Mycoplasma faucium 
HMT606
0.002838 3.846154 0.075078827 72.41379 0.004729376 19.23077 3.93E-10
Tannerella forsythia 
HMT613
0.011631 38.46154 0.07827513 82.75862 0.007009139 38.46154 2.74E-08
Peptostreptococcaceae [XI]
[G-6] nodatum HMT694
0.000757 3.846154 0.021276436 55.17241 0.00195116 7.692308 6.52E-08
Porphyromonas gingivalis 
HMT619
0.000000 0 0.049856888 50 0.000804377 5.769231 1.22E-07
Filifactor alocis HMT539 0.012395 15.38462 0.135676421 63.7931 0.015349738 21.15385 2.65E-07
Rothia dentocariosa 
HMT587
0.022593 23.07692 0.091595477 65.51724 0.003578482 17.30769 7.87E-07
Bacteroidaceae [G-1] 
HMT272
0.005529 15.38462 0.001228553 6.896552 0.015004592 50 7.49E-06
Treponema sp.HMT237 0.010219 15.38462 0.045178271 50 0.002571879 11.53846 8.10E-06
Mogibacterium timidum 
HMT042
0.030495 46.15385 0.106152765 82.75862 0.026568563 53.84615 1.34E-05
Fusobacterium nucleatum 
HMT200
0.066781 42.30769 0.257576702 77.58621 0.07180377 48.07692 3.15E-05
Treponema denticola 
HMT584
0.009736 23.07692 0.040443669 48.27586 0.001278036 9.615385 4.14E-05
Fretibacterium fastidiosum 
HMT363
0.005070 19.23077 0.032599761 53.44828 0.003339819 17.30769 4.14E-05
Prevotella intermedia 
HMT643
0.034083 30.76923 0.244041221 62.06897 0.031503929 23.07692 5.05E-05
Peptostreptococcaceae [XI]
[G-5] saphenum HMT759
0.011885 11.53846 0.076931378 53.44828 0.007156812 23.07692 5.14E-05
Porphyromonas 
endodontalis HMT273
0.090996 61.53846 0.319207693 87.93103 0.084759485 69.23077 6.89E-05
Fretibacterium sp.HMT360 0.004001 19.23077 0.024301347 51.72414 0.002661645 15.38462 7.59E-05
Peptostreptococcaceae [XI]
[G-4] HMT369
0.001159 11.53846 0.008681835 44.82759 0.001356973 9.615385 1.60E-04
Abbreviation: RA, relative abundance.
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F I G U R E  2   Linear discriminant effect size analysis. Linear discriminant analysis score expressed as (log 10) of significant bacterial taxa. (a) 
Psoriasis (PS) versus periodontitis (P). (b) Psoriasis (PS) versus healthy controls (HC). (c) Periodontitis (P) versus healthy controls (HC)
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However, a study from 2015 showed higher salivary levels of pro-in-
flammatory cytokines, including tumor necrosis factor-α, IL-1β, 
transforming growth factor-1β, and monocyte chemoattractant 
protein-1 in patients with psoriasis as compared to orally healthy 
controls (Ganzetti et al., 2015). Therefore, psoriasis seems to asso-
ciate with increased levels of inflammatory markers in saliva and it 
is remarkable that in our study patients with psoriasis had signifi-
cantly lower levels of salivary NGAL as compared to patients with 
periodontitis and orally healthy controls, respectively. NGAL is an 
inflammation-related protein, and increased levels of NGAL in the 
circulation and urine have been intensively investigated as a marker 
of acute kidney injury (Hjortrup, Haase, Treschow, Møller, & Perner, 
2015). Also, in periodontitis a positive correlation has been found 
between urinary levels of NGAL and the severity of periodontitis 
(Nakajima et al., 2019). Notably, in a study from 1996, increased ex-
pression of NGAL was identified in gingival tissue and saliva from 
patients with periodontitis (Westerlund et al., 1996), and a recent re-
port showed that experimental gingivitis caused an increase in sali-
vary levels of NGAL (Morelli et al., 2014). Furthermore, higher NGAL 
levels in local samples, that is, gingival crevicular fluid (GCF), were 
reported in patients with periodontitis (Pradeep, Nagpal, Karvekar, 
& Patnaik, 2016). The present salivary NGAL data are therefore 
intriguing and warrant further study, but it is remarkable that con-
flicting data also exist for other salivary inflammatory markers in 
periodontitis, for example, with increased (Lee et al., 2018) or similar 
(Moura et al., 2017) salivary levels of IL-1β compared to healthy con-
trols. While the main contributor to salivary proteins is the circula-
tion, with proteins shed from local oral surfaces playing a lesser role 
(Lynge Pedersen & Belstrom, 2019), disease-specific mechanisms are 
likely to be involved, for example, with periodontitis-dependent in-
creased expression of inflammatory mediators in the inflamed oral 
tissue potentially being countered by increased local tissue binding 
or other interactions that contribute to unpredictability of salivary 
levels of these molecules. It would therefore be recommendable to 
include blood and GCF samples in future studies on salivary levels of 
inflammation-related proteins.
Also, salivary transferrin levels were lower in patients with psori-
asis compared to patients with periodontitis and orally healthy con-
trols, respectively. Transferrin is a “negative” inflammation-related 
protein, and inflammation is associated with a decrease in circulating 
transferrin levels. Accordingly, several studies have reported that 
periodontal treatment is associated with an increase in blood trans-
ferrin levels, albeit that to our knowledge, there is no evidence avail-
able on salivary transferrin levels (Fang et al., 2015; Shirmohamadi 
et al., 2016).
Some limitations apply to the present study, primarily the rela-
tively low number of included patients with psoriasis. However, as 
significant differences in the salivary microbiota and salivary levels 
of NGAL and transferrin, respectively, were observed, the number 
of participants may have been sufficient. Furthermore, the sever-
ity of psoriasis and current treatment regimen was not recorded but 
we recently found that similar patients with psoriasis from the re-
cruiting hospital had a psoriasis area and severity index (PASI) score 
of approximately 10 suggestive of severe disease (Ahlehoff et al., 
2011). Moreover, as blood samples and local samples from the oral 
cavity, for example, GCF, were not collected, it was not possible to 
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compare salivary, local, and circulating levels of NGAL and transfer-
rin. In addition, the higher amount of current smokers in the peri-
odontitis group may have influenced data on the salivary microbiota, 
as smoking status has been reported to influence the composition 
of the subgingival microbiota (Mason et al., 2015). However, previ-
ous studies have shown that the impact of smoking on the salivary 
microbiota is probably not as pronounced (Belstrøm, Fiehn, et al., 
2014; Belstrøm, Holmstrup, et al., 2014). Finally, the prevalence of 
cardiovascular disease and diabetes in patients with psoriasis was 
in the present study somewhat lower than expected, which might 
be explained by the fact that cardiovascular disease and diabetes 
was self-reported and therefore not based on data from a medical 
examination.
In conclusion, data from the present study suggest that psoriasis 
is associated with characteristics of the salivary microbiota and sali-
vary levels of inflammation-related proteins, which is different from 
that of patients with periodontitis and orally healthy controls. More 
studies are needed to shed further light on the mechanisms underly-
ing the association between psoriasis and periodontitis.
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